GAVILIMOMAB
UNII TCR92293RC

Substance Identification & Data

This profile provides standardized clinical and technical data for Gavilimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TCR92293RC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 244096-20-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TCR92293RC
CAS Registry Number
244096-20-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GAVILIMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8060
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gavilimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GAVILIMOMAB

Common Names & Synonyms

GAVILIMOMAB [INN]
GAVILIMOMAB [WHO-DD]
IMMUNOGLOBULIN M, ANTI-(HUMAN ANTIGEN CD147) (MOUSE MONOCLONAL ABX-CBL M-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL ABX-CBL LIGHT CHAIN, PENTAMER

Technical Codes

ABX-CBL